A Thousand Years Along the Silk Road, a New Journey in Medicine—The 31st Uzbekistan International Healthcare and Pharmaceutical Exhibition (TIHE) in 2027 invites you to join us in exploring the untapped potential of Central Asia’s healthcare market.

Tashkent, the crossroads of Central Asia. Two thousand years ago, the jingling of camel bells carried medicinal herbs and medical texts through these lands, weaving a lifeline that connected Eastern and Western civilizations; two millennia later, From April 20 to 22, 2027, the 31st Uzbekistan International Healthcare and Pharmaceutical Exhibition (TIHE 2027) will once again be held on the same venue, welcoming healthcare companies and buyers from around the world. The Silk Road has never been interrupted; it has merely taken on new forms.

Since its inception in 1995, TIHE has been deeply rooted in Central Asia for three decades. As the only medical trade show in Uzbekistan accredited by the Global Association of the Exhibition Industry (UFI), and with the joint support of official bodies including the Ministry of Health, the Ministry of Investment, Industry and Trade, the Agency for the Development of the Pharmaceutical Industry, and the Chamber of Commerce and Industry, it has become the most influential B2B platform for the healthcare sector in Central Asia.

For the past thirty years, TIHE has been more than just an exhibition—it has served as a strategic gateway to the Central Asian healthcare market.

Data confirms the popularity.

Why exhibit at TIHE 2027?

Uzbekistan, with a population of 37.54 million, ranks first in Central Asia and serves a regional consumer base of over 76 million. In recent years, its medical device market has maintained a robust double-digit compound annual growth rate, driven by strong momentum. However, domestic production capacity remains limited, with more than 90% of registered devices relying on imports; mid- to high-end equipment such as CT scanners, MRI machines, ultrasound systems, and IVD products are heavily dependent on overseas procurement.

Uzbekistan is currently at a critical stage of comprehensively upgrading its healthcare system. The government continues to increase investment in healthcare, with public hospitals undergoing renovation and expansion, and the development of primary‑care networks progressing in an orderly manner. At the same time, import tariffs on medical devices have been reduced, registration procedures have been streamlined, and market entry barriers have been steadily lowered. The combined effect of these favorable policies has created a rare window of opportunity for overseas healthcare companies to enter the Central Asian market.

TIHE implements a B2B professional access program, attracting attendees primarily from hospital administrators, heads of medical equipment departments, national general agents, procurement managers at chain clinics, and pharmaceutical wholesalers. Sixty percent of the audience holds purchasing decision‑making authority or influence, enabling on‑site discussions on annual distribution frameworks and bulk tender orders.

Tashkent is connected to Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Afghanistan. Among the attendees, 72% hail from Tashkent and Tashkent Region, while the remainder come from other parts of Uzbekistan and across Central Asia—exhibiting at TIHE enables you to efficiently reach the region’s key purchasing decision‑makers.

China is Uzbekistan’s largest trading partner, and the two countries have established an “all‑weather, comprehensive strategic partnership for the new era” and are jointly building a “Health Silk Road.” High‑value‑for‑money products spearheaded by Chinese companies—such as imaging equipment, patient monitors, IVD diagnostics, and medical consumables—are precisely aligned with the procurement budgets of both public and private healthcare institutions in Uzbekistan. The participation of 116 Chinese enterprises at TIHE 2026 stands as compelling evidence of this strong market fit.

Premium booth reservations are now open.

Thirty years of experience and trust

Deal after deal, collaboration after collaboration.

——

TIHE has been proven by time.

The core value of our presence in the Central Asian healthcare market